Skip to main content

Varicella virus vaccine Disease Interactions

There are 2 disease interactions with varicella virus vaccine.

Major

Vaccination (applies to varicella virus vaccine) infections

Major Potential Hazard, High plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral, Fever

Ideally, vaccination should occur when an individual is healthy, thus minimizing the risk of an adverse host reaction and/or vaccine failure. However, a current or recent infection does not necessarily preclude the use of vaccines, depending on the severity of the patient's symptoms and their etiology. Superficial infections and minor acute illnesses such as a mild upper respiratory infection with or without low-grade fever do not contraindicate immunization, particularly if prompt administration of a vaccine is deemed necessary or beneficial. In fact, when vaccines are administered during the course of a minor illness, the risk of adverse events is not increased, and serum antibody response is not often diminished. On the other hand, if fever or symptoms suggest a moderate or severe illness, it is usually appropriate to withhold vaccination until the patient has recovered. In addition to the potential risks already mentioned, evolving signs and symptoms of the illness can sometimes confound the diagnosis of a vaccine reaction if it develops. In the presence of any infection, the decision to administer or withhold/defer immunization should take into consideration the benefits versus the risks to an individual patient.

References

  1. "Product Information. Typhim VI (typhoid vaccine, inactivated)." Apothecon Inc (2022):
  2. "Product Information. Varivax (varicella virus vaccine)." Merck & Co., Inc (2022):
  3. "Product Information. Pneumovax 23 (pneumococcal 23-polyvalent vaccine)." Merck & Co., Inc (2022):
  4. "Product Information. Mumpsvax (mumps virus vaccine)." Merck & Co., Inc (2022):
  5. "Product Information. Meruvax II (rubella virus vaccine)." Merck & Co., Inc (2022):
  6. "Product Information. Attenuvax (measles virus vaccine)." Merck & Co., Inc (2022):
  7. "Product Information. Orimune (poliovirus vaccine, live, trivalent)." Lederle Laboratories (2022):
  8. "Product Information. YF-Vax (yellow fever vaccine)." sanofi pasteur PROD (2001):
  9. "Product Information. Omnihib (haemophilus b conjugate vaccine (obsolete))." SmithKline Beecham PROD
  10. "Product Information. Menomune A/C/Y/W-135 (meningococcal polysaccharide vaccine)." Connaught Laboratories Inc
  11. "Product Information. Plague Vaccine (plague vaccine)." Greer Laboratories Inc PROD (2001):
  12. American Academy of Pediatrics. Committee on Infectious Diseases; Peter G, ed. "Red BooK: Report of the Committee on Infectious Diseases." Grove Village, IL: American Academy of Pediatrics (1997):
  13. "Product Information. Cholera Vaccine (cholera vaccine)." Wyeth-Ayerst Laboratories PROD
  14. "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham PROD
  15. "Product Information. Engerix-B (HepB) (hepatitis B adult vaccine)." Apothecon Inc (2022):
  16. "Product Information. Zostavax (zoster vaccine live)." Merck & Co., Inc (2006):
  17. "Product Information. Gardasil (human papillomavirus vaccine)." Merck & Co., Inc (2006):
  18. "Product Information. Gardasil 9 (human papillomavirus vaccine)." Merck & Co., Inc (2016):
View all 18 references
Major

Varicella vaccine (applies to varicella virus vaccine) immunodeficiency

Major Potential Hazard, High plausibility.

In general, the use of varicella virus vaccine is contraindicated in patients with primary or acquired immunodeficiency or infection with HIV. Since varicella virus vaccine contains live attenuated virus, the absence of immune competence may potentiate the replication of vaccine virus, increase adverse host reactions, and compromise serum antibody response. The vaccine should not be administered to immunosuppressed or immunodeficient individuals and those receiving immunosuppressive therapy, including individuals receiving immunosuppressive doses of corticosteroids as it may cause an extensive vaccine-associated rash or disseminated disease in these individuals.

References

  1. "Product Information. Varivax (varicella virus vaccine)." Merck & Co., Inc (2022):
  2. American Academy of Pediatrics. Committee on Infectious Diseases; Peter G, ed. "Red BooK: Report of the Committee on Infectious Diseases." Grove Village, IL: American Academy of Pediatrics (1997):
  3. "Product Information. Zostavax (zoster vaccine live)." Merck & Co., Inc (2006):

Varicella virus vaccine drug interactions

There are 329 drug interactions with varicella virus vaccine.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.